Navigation Links
Insmed in Medical News

Insmed Provides Update on Supply of IPLEX(TM)

... RICHMOND, Va., July 27 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...g facility to Merck & Co., Inc. in March 2009, insmed no longer has the capability to manufacture IPLEX(...o consider its development options." About insmed ...

Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

... RICHMOND, Va., March 31 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...erck & Co., Inc. As a result of this closing, insmed has now received $130 million, the aggregate purch...d positions to employees of the Boulder facility. insmed has retained its Richmond, VA corporate office, wh...

Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND

... RICHMOND, Va., March 10 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on b...casermin_rinfabate/FDA_statement.htm . About insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants

... RICHMOND, Va., Jan. 21 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on ... target="_new"> info@premacure.com . About insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs

... RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol... today announced that Genentech, Ipsen/Tercica and insmed jointly issued the following statement: Genentech, Ipsen/Tercica, and insmed have been contacted by people living with Amyotrop...

Global Growth Factors (Blood and Tissue) Market to Reach $52.1 Billion by 2012, According to New Report by Global Industry Analysts

...imetic Therapeutics Inc, Biopharm GmbH, Bolder Biotechnology Inc, Alseres Pharmaceuticals Inc, Ceregene Inc, FibroGen Inc, FzioMed Inc, GeneMedix Plc, insmed Inc, Johnson & Johnson, Janssen-Ortho Inc, Lonza Group, Maxygen Inc, Merck Serono International SA, NsGene A/S, PeproTech Inc, Rentschler Biotechn...

Insmed to Present at Upcoming Healthcare Conferences

... RICHMOND, Va., Nov. 5 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol... and CEO of Insmed, and Steve Glover, President of insmed Therapeutic Proteins, will be presenting at the 17...archived for a period of 90 days. About Insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference

... RICHMOND, Va., Dec. 6 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceutic...ce through access to these innovative follow-on biologics. About Insmed insmed Inc. is a biopharmaceutical company with unique protein process development...
Insmed in Medical Technology

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)

... RICHMOND, Va., Oct. 14 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...t recorded 2007 sales of approximately $1 billion. insmed intends to seek approval of INS-19 and INS-20 in t... biologic version of Neulasta(R). About Insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed CEO to Present at Congressional Briefing on Follow-On Biologics

... RICHMOND, Va., July 22 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq CM: INSM) a developer of follow-on bi...reased innovation in the field of biotechnology. insmed intends to request a meeting with the FDA to discu... combined 2007 worldwide sales of over $4 billion. insmed plans to launch its follow-on biologic versions of...

Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company

...MOND, Va., July 10, 2008 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on bi...s can be a scientific reality in the U.S. and that insmed is well positioned to be a leader in the field. De...of generic drugs today. Thus, based on these data, insmed intends to request a meeting with the FDA to discu...

Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs

...ALS Expanded Access Program Continues to Enroll - insmed Generates $2.3 million in Cost Recovery Revenue Th... RICHMOND, Va., April 29 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...velopment program. Follow-On Biologics Program insmed recently received regulatory approval from the Uni...

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)

...es Regulatory Clearance RICHMOND, Va., April 16 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceutic...trates that the products have a high degree of similarity. About Insmed insmed Inc. is a biopharmaceutical company with unique protein process development...

Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics

... RICHMOND, Va., Feb. 5 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...ry pathway currently exists for FOBs in the U.S. insmed has launched a number of public initiatives to pro...educe costs for expensive biotech drugs. Following insmed CEO Geoffrey Allan's recent testimony before the U...

Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis

...ecovery from EAP in 2007 RICHMOND, Va., Jan. 24 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceutic...ed for various other indications with unmet medical needs. About Insmed insmed Inc. is a biopharmaceutical company with unique protein process development...

Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy

... RICHMOND, Va., Dec. 18 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...he treatment of Myotonic Muscular Dystrophy (MMD). insmed is currently conducting a 24-week Phase III enabli...s Orphan Drug Designation is another milestone for insmed in our development and commercialization plan for ...

Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study

... RICHMOND, Va.--(BUSINESS WIRE)--Apr 30, 2007 - insmed Inc., (Nasdaq:INSM) today announced positive resul...re information, please visit www.ucsf.com. About insmed insmed is a biopharmaceutical company focused on the deve...

Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study

... RICHMOND, Va.--(BUSINESS WIRE)--May 3, 2007 - insmed Inc. (Nasdaq:INSM) today announced positive result...ise known as ALS or Lou Gehrig's disease). About insmed insmed is a biopharmaceutical company focused on the deve...
Insmed in Biological Technology

Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine

LOCATION: http://content.onstreammedia.com/content/multivu/18240/31602.mp3 RICHMOND, VA, January 29 /PRNewswire/ -- The American Magazine has just released a Podcast interview with Insmed Therapeutic Proteins President Steve Glover on how a generic, or follow-on biologics, industry is good fo...

Insmed to Host Second Quarter 2009 Conference Call

... RICHMOND, Va., July 31 /PRNewswire/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...ts financial results for the second quarter 2009. insmed intends to issue its quarterly financial results p...rnational), using passcode 53658791. About insmed ...

Insmed Announces Addition to the Russell 3000(R) Index

... RICHMOND, Va., June 30 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan... U.S. and global equity indexes on June 26, 2009. insmed was also added to the Russell Microcap(R) Index. ...stern Mutual Life Insurance Company. About insmed ...

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

... - insmed to Evaluate Potential Initiation of Phase II Trial...RICHMOND, Va. , June 25 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...itive function, gastrointestinal function or pain, insmed was unable to reach any conclusions regarding the ...

Insmed CEO Resigns Due to Health Concerns

... RICHMOND, Va., June 15 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...lan has played a critical role in the evolution of insmed from its inception, navigating the Company through...encountered within the biotech sector, and putting insmed in an envied position of financial strength in the...

Insmed Announces First Quarter 2009 Financial Results

... RICHMOND, Va., May 13 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...nd Net of finance and legal fees paid, insmed has received net proceeds to date of approximately... The FDA announced that it would allow insmed to provide access to IPLEX(TM) for investigational...

Insmed Regains NASDAQ Compliance

... RICHMOND, Va., May 5 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...stock price had closed above $1.00 per share. insmed will continue to trade on The NASDAQ Capital Marke... bid price compliance is now closed. About insmed ...

Insmed to Host First Quarter 2009 Conference Call

... RICHMOND, Va., April 23 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq CM: INSM ), a biopharmaceutical co...its financial results for the first quarter 2009. insmed intends to issue its quarterly financial results p...national), using passcode 62249241. About insmed ...

Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)

... insmed WILL CONTINUE TO MANAGE ALS EAP IN ITALY AND ALL I... RICHMOND, Va., March 30 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...oved in their country. Under the agreement, insmed will continue to be responsible for the IPLEX(TM) ...

Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule

... RICHMOND, Va., March 25 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on b... reinstated on Monday, April 20, 2009. About insmed insmed Inc. is a biopharmaceutical company with unique pr...
Other Tags
(Date:7/11/2014)... IN (PRWEB) July 11, 2014 New Albany ... be startled with the idea of paying $20,000 for new teeth. ... makes it worth it for many patients,” Dr. Receveur said. , ... foods they love, or have a lifetime of embarrassment over their ... – they’re paying for a better, more enjoyable life. , Still, ...
(Date:7/10/2014)... CO (PRWEB) July 11, 2014 Karen ... Cowart, President and CEO of Planned Parenthood of the ... fact Senator Mark Udall and Representative Diana DeGette were ... Supreme Court’s Hobby Lobby decision and keeping bosses out ... PPRM representatives listened to the president today in Denver ...
(Date:7/10/2014)... 10, 2014 Ticketability.com has a wide array ... Paul McCartney tickets for San Diego are being added to ... since 1976, and the newly added September 28 show is ... Click Here to view the selection of discounted ... Park will become available to the general public on July ...
(Date:7/10/2014)... York City, NY (PRWEB) July 10, 2014 ... the life sciences industry, has launched a new website. ... responsiveness, as well as increased access to the firm’s ... new cbpartners.com provides an ideal platform to showcase our ... health access issues,” says CBPartners’ Chief Executive Officer, Cyrus ...
(Date:7/10/2014)... 10, 2014 Ivalua, the global ... of the 4th “Trending in Procurement” report on ... , Every day multinational corporations process thousands of ... etc. To meet this challenge, more and more ... can be defined as a suite of integrated ...
Breaking Medicine News(10 mins):Health News:Louisville Dental Expert Offers 5 Tips for Deciding Whether Cost or Value of Dental Implants are More Important 2Health News:Louisville Dental Expert Offers 5 Tips for Deciding Whether Cost or Value of Dental Implants are More Important 3Health News:Louisville Dental Expert Offers 5 Tips for Deciding Whether Cost or Value of Dental Implants are More Important 4Health News:Naral Pro-Choice Colorado & Planned Parenthood Of The Rocky Mountains Statement On Udall & Degette Staying In Dc To Introduce Legislation 2Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:CBPartners Announces New Website 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 3
(Date:7/11/2014)... to study the proteins that let nerve cells send ... stumbled upon a biological tactic that may offer a ... a safe and environmentally responsible way. , Their ... one species and harmless for a closely related onesuggests ... without harming beneficial species like bees. A summary of ...
(Date:7/11/2014)... In the brains of all vertebrates, information is ... electric or chemical signal to be passed from ... are the most abundant type of synapse, can ... crucial for learning, memory, perception and cognition, and ... for brain function. For instance, every time ...
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3Blame it on the astrocytes 2'Tailored' water -- the latest in lawn care 2
Other Contents